@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix go: . @prefix Protein: . @prefix mgi: . @prefix geneProductOf: . @prefix hasAgent: . @prefix RNA: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasAgent: sub:_2; a go:0042789 . sub:_2 geneProductOf: mgi:99458; a Protein: . sub:_3 geneProductOf: mgi:97253; a RNA: . sub:_4 occursIn: species:10090; rdf:object sub:_3; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "tscript(p(MGI:Mef2c)) -> r(MGI:Myf6)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_6; pav:version "20131211" . sub:_5 prov:value "We cotransfected pMRF4.CAT into 10T1/2 fibroblasts along with activator plasmids encoding one of the four myogenic bHLH factors or MEF2A, MEF2C, or MEF2D. As shown in Fig. 3, myogenin, myf5, and MyoD all mediate a strong trans-activation (about 20-fold) of the MRF4 promoter. In contrast, MRF4 was unable to activate its own promoter in this assay. All of the MEF2 factors tested were able to reproducibly activate the MRF4 promoter from 4-10-fold."; prov:wasQuotedFrom pubmed:7852366 . sub:_6 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:7852366; prov:wasDerivedFrom beldoc:, sub:_5 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:47.051+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }